Longwood Fund II, L.P., 10% Owner at Flex Pharma, Inc. (FLKS), sold 6,425,722 shares at $0.92 ($5.9M) on 2018-10-16, disclosed to the SEC on 2018-10-18.
Open-market sale of $5.9M FLKS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.92 | 3,212,861 | $3.0M | 50.0% |
| 2 | $0.92 | 3,212,861 | $3.0M | 50.0% |
| Total | $0.92 avg | 6,425,722 | $5.9M | 100% |
| Filing → |